PI3K/AKT pathway involvement in the osteogenic effects of osteoclast culture supernatants on preosteoblast cells

Tissue Engineering - Part A

Volumn 19, Issue 19-20, 2013, Pages 2226-2232

  Chen, Li Li ^a   Huang, Mei ^a   Tan, Jing Yi ^a   Chen, Xiao Tao ^a   Lei, Li Hong ^a   Wu, Yan Min ^a   Zhang, Di Ya ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMINERALIZATION; CELL CULTURE; CELLS; PHOSPHATASES; POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY;

ALKALINE PHOSPHATASE; COLONY-STIMULATING FACTOR; MATRIX MINERALIZATION; OSTEOCLAST DIFFERENTIATION; OSTEOGENIC EFFECTS; PHOSPHATIDYLINOSITOL 3-KINASE; TARTRATE-RESISTANT ACID PHOSPHATASE; WESTERN-BLOT ANALYSIS;

BONE;

2 MORPHOLINO 8 PHENYLCHROMONE; COLONY STIMULATING FACTOR; COLONY STIMULATING FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CALCIFICATION; CELL DIFFERENTIATION; CELL LINE; CORTICAL BONE; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; SUPERNATANT;

BOVINE RESPIRATORY SYNCYTIAL VIRUS;

ANIMALS; CELL LINE; MICE; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84883715714     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0469     Document Type: Article

References (33)

1. Galli, C., Passeri, G., and Macaluso, G.M. FoxOs, Wnts and oxidative stress-induced bone loss: new players in the periodontitis arena? J Periodont Res 46, 397, 2011.
2. Zheng, Y., Wu, G., Zhao, J., Wang, L., Sun, P., and Gu, Z. rhBMP2/7 heterodimer: anosteoblastogenesis inducer of not higher potency but lower effective concentration compared with rhBMP2 and rhBMP7 homodimers. Tissue Eng PartA 16, 879, 2010.
3. Martin, T.J., and Sims, N.A. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med 11, 76, 2005.
4. Kubota, K., Sakikawa, C., Katsumata, M., Nakamura, T., and Wakabayashi, K. Platelet-derived growth factor BB secreted from osteoclasts acts as anosteoblastogenesis inhibitory factor. J Bone Miner Res 17, 257, 2002.
5. Ash, P., Loutit, J.F., and Townsend, K.M. Osteoclasts derived from haematopoietic stem cells. Nature 283, 669, 1980.
6. Manolagas, S.C., and Jilka, R.L. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332, 305, 1995.
7. Silva, I., and Branco, J.C. Rank/Rankl/opg: literature review. Acta Reumatol Port 36, 209, 2011.
8. Matsuo, K., and Irie, N. Osteoclasts-osteoblasts communication. Arch Biochem Biophys 473, 201, 2008.
9. Hattner, R., and Frost, H.M. Fluorescence of tetracyclines in bone. Absorption maximum, hydration shell and polarization effects. J Surg Res 2, 262, 1962.
10. Naumann, R.W. The role of the phosphatidylinositol 3-kinkinase (PI3K) pathway in the development and treatment of uterine cancer. Gynecol Oncol 123, 411, 2011.
11. Ghosh-Choudhury, N., Abboud, S.L., Nishimura, R., Celeste, A., Mahimainathan, L., and Choudhury, G.G. Requirement of BMP-2-induced phosphatidylinositol 3-kinase andAkt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. J Biol Chem 277, 33361, 2002.
12. Mukherjee, A.,Wilson, E.M., and Rotwein, P. Selective signaling by Akt2 promotes bone morphogenetic protein2-mediated osteoblast differentiation. Mol Cell Biol 30, 1018, 2010.
13. Sudo,H.,Kodama,H.A., andAmagai, Y. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 96, 191, 1983.
14. Moffat, J., Grueneberg, D.A., Yang, X., Kim, S.Y., Kloepfer, A.M., Hinkle, G., Piqani, B., Eisenhaure, T.M., Luo, B., Grenier, J.K., Carpenter, A.E., Foo, S.Y., Stewart, S.A., Stockwell, B.R., Hacohen, N., Hahn, W.C., Lander, E.S., Sabatini, D.M., and Root, D.E. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral highcontent screen. Cell 124, 1283, 2006.
15. Stanford, C.M., Jacobson, P.A., Eanes, E.D., Lembke, L.A., and Midura, R.J. Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). J Biol Chem270, 9420, 1995.
16. Hoemann, C.D., El-Gabalawy, H., and McKee, M.D. In vitro osteogenesis assays: influence of the primary cell source on alkaline phosphatase activity and mineralization. Pathol Biol 57, 318, 2009.
17. Nakano-Kurimoto, R., Ikeda, K., Uraoka, M., Nakagawa, Y., Yutaka, K., Koide, M., Takahashi, T., Matoba, S., Yamada, H., Okigaki, M., and Matsubara, H. Replicative senescence of vascular smooth muscle cells enhances the calcification through initiating the osteoblastic transition. Am J Physiol Heart Circ Physiol 297, H1673, 2009.
18. Ferron, M., Wei, J., Yoshizawa, T., Ducy, P., and Karsenty, G. An ELISA-based method to quantify osteocalcin carboxylation in mice. Biochem Biophys Res 397, 691, 2010.
19. Wang, Y., Nishida, S., Elalieh, H.Z., Long, R.K., Halloran, B.P., and Bikle, D.D. Role of IGF-I signaling in regulating osteoclastogenesis. J Bone Miner Res 21, 1350, 2006.
20. Rici, R.E., Alcâ ntara, D., Fratini, P., Wenceslau, C.V., Ambro ́ sio, C.E., Miglino, M.A., and Maria, D.A. Mesenchymal stem cells with rhBMP-2 inhibits the growth of canine osteosarcoma cells. BMC Vet Res 22, 8, 2012.
21. Ryu, J., Kim, H.J., Chang, E.J., Huang, H., Banno, Y., and Kim, H.H. Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling. EMBO J 25, 5840, 2006.
22. Sefcik, L.S., Petrie Aronin, C.E., Wieghaus, K.A., and Botchwey, E.A. Sustained release of sphingosine 1-phosphate for therapeutic arteriogenesis and bone tissue engineering. Biomaterials 29, 2869, 2008.
23. Mehrotra, M., Krane, S.M., Walters, K., and Pilbeam, C. Differential regulation of platelet-derived growth factor stimulated migration and proliferation in osteoblastic cells. J Cell Biochem 93, 741, 2004.
24. Yao, G.Q., Wu, J.J., Sun, B.H., Troiano, N., Mitnick, M.A., and Insogna, K. The cell surface form of colony-stimulating factor-1 is biologically active in bone in vivo. Endocrinology1 44, 3677, 2003.
25. Burton, D.G., Matsubara, H., and Ikeda, K. Pathophysiology of vascular calcification: pivotal role of cellular senescence in vascular smooth muscle cells. Exp Geronto l45, 819, 2010.
26. Mundy, G.R., and Elefteriou, F. Boning up on ephrin signaling. Cell 126, 441, 2006.
27. Anderson, R.E., Kemp, J.W., Jee, W.S., and Woodbury, D.M. Ion transporting ATP-ase and matrix mineralization in cultured osteoblast-precursor cells. In Vitro 20, 837, 1984.
28. Maniatopoulos, C., Sodek, J., and Melcher, A.H. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res 254, 317, 1988.
29. Zhao, C., Irie, N., Takada, Y., Shimoda, K., Miyamoto, T., Nishiwaki, T., Suda, T., and Matsuo, K. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab 4, 111, 2006.
30. Mitchell, S.A., Danca, M.D., Blomgren, P.A., Darrow, J.W., Currie, K.S., Kropf, J.E., Lee, S.H., Gallion, S.L., Xiong, J.M., Pippin, D.A., DeSimone, R.W., Brittelli, D.R., Eustice, D.C., Bourret, A., Hill-Drzewi, M., Maciejewski, P.M., and Elkin, L.L. Imidazo[1,2-a]pyrazine diaryl ureas: inhibitors of the receptor tyrosine kinase EphB4. Bioorg Med Chem Lett, 19, 6991, 2009.
31. Blume-Jensen, P., and Hunter, T. Oncogenic kinase signalling. Nature 411, 355, 2001.
32. Hubbard, S.R. Autoinhibitory mechanisms in receptor tyrosine kinases. Front Biosci 7, 330, 2002.
33. Moritz, A., Li, Y., Guo, A., Villén, J., Wang, Y., MacNeill, J., Kornhauser, J., Sprott, K., Zhou, J., Possemato, A., Ren, J.M., Hornbeck, P., Cantley, L.C., Gygi, S.P., Rush, J., and Comb, M.J. Akt-RSK-S6 kinase signaling networks activated by oncogenic receptor tyrosine kinases. Sci Signal 24, 3, 2010.